Order Article Reprints

Caballero A, Vazquez-Sanchez T, Ruiz-Esteban P, Leon M, Alonso-Titos J, Lopez V, Sola E, Gutierrez E, Cabello M, Casas-Gonzalez C, et al. Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation. Journal of Clinical Medicine. 2021; 10(21):5051. https://doi.org/10.3390/jcm10215051

Caballero, Abelardo, Teresa Vazquez-Sanchez, Pedro Ruiz-Esteban, Myriam Leon, Juana Alonso-Titos, Veronica Lopez, Eugenia Sola, Elena Gutierrez, Mercedes Cabello, Cristina Casas-Gonzalez, and et al. 2021. "Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation" Journal of Clinical Medicine 10, no. 21: 5051. https://doi.org/10.3390/jcm10215051

Caballero, A., Vazquez-Sanchez, T., Ruiz-Esteban, P., Leon, M., Alonso-Titos, J., Lopez, V., Sola, E., Gutierrez, E., Cabello, M., Casas-Gonzalez, C., Pozo-Alvarez, R., Delgado-Burgos, J., & Hernandez, D. (2021). Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation. Journal of Clinical Medicine, 10(21), 5051. https://doi.org/10.3390/jcm10215051